Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Filter
  • 1-10 ل  1,886 نتائج ل ""Arthritis, Rheumatoid""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Preferable effect of CTLA4-Ig on both bone erosion and bone microarchitecture in rheumatoid arthritis revealed by HR-pQCT.

  • Authors : Iwamoto N; Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. .; Chiba K

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/diagnostic imaging ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/pathology

  • Source: Scientific reports [Sci Rep] 2024 Nov 12; Vol. 14 (1), pp. 27673. Date of Electronic Publication: 2024 Nov 12.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Effective Assessment of Rheumatoid Arthritis Disease Activity and Outcomes Using Monocyte Chemotactic Protein-1 (MCP-1) and Disease Activity Score 28-MCP-1.

  • Authors : Tsai PH; Division of Rheumatology, Allergy, and Immunology, New Taipei Municipal Tucheng Hospital, New Taipei City 236, Taiwan.; Division of Rheumatology, Allergy, and Immunology, Chang Gung Memorial Hospital at Linkou, Taoyuan City 333, Taiwan.

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/pathology ; Chemokine CCL2*

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Oct 23; Vol. 25 (21). Date of Electronic Publication: 2024 Oct 23.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

×
Academic Journal

Red blood cell metabolomics identify ergothioneine as a key metabolite in DMARD-naïve rheumatoid arthritis and response to methotrexate.

  • Authors : Sigaux J; Inserm U1125, Université Sorbonne Paris Nord, Bobigny, France.; Rheumatology Department, Assistance Publique-Hôpitaux de Paris, GH HUPSSD, Bobigny, France.

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/blood ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/metabolism

  • Source: Scientific reports [Sci Rep] 2024 Sep 09; Vol. 14 (1), pp. 21005. Date of Electronic Publication: 2024 Sep 09.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Multiscale, mechanistic model of Rheumatoid Arthritis to enable decision making in late stage drug development.

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Drug Development*/Drug Development*/Drug Development*/methods ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use

  • Source: NPJ systems biology and applications [NPJ Syst Biol Appl] 2024 Nov 04; Vol. 10 (1), pp. 126. Date of Electronic Publication: 2024 Nov 04.Publisher: Nature Publishing Group in partnership with SBI, The Systems Biology Institute Country of Publication: England NLM ID: 101677786 Publication Model:

تفاصيل العنوان

×
Academic Journal

Treat-to-target fixed dose rituximab retreatment versus fixed interval retreatment with disease activity-guided rituximab dose optimisation for patients with rheumatoid arthritis: study protocol for a multicentre randomised controlled superiority trial focusing on long-term disease impact (RITUXERA).

  • Authors : De Meyst E; KU Leuven, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, Herestraat 49, Leuven, 3000, Belgium. .; UZ Leuven, Rheumatology, Leuven, Belgium. .

Subjects: Rituximab*/Rituximab*/Rituximab*/administration & dosage ; Rituximab*/Rituximab*/Rituximab*/adverse effects ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy

  • Source: Trials [Trials] 2024 Oct 15; Vol. 25 (1), pp. 681. Date of Electronic Publication: 2024 Oct 15.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

×
Academic Journal

Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina.

  • Authors : Espinola N; Instituto de Efectividad Clínica y Sanitaria, Ciudad de Buenos Aires, Argentina.; Secco A

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/economics ; Budgets*

  • Source: Revista peruana de medicina experimental y salud publica [Rev Peru Med Exp Salud Publica] 2024 Aug 19; Vol. 41 (2), pp. 129-139. Date of Electronic Publication: 2024 Aug 19.Publisher: Instituto Nacional de Salud Country of Publication: Peru NLM ID: 101227566 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Designing target trials using electronic health records: A case study of second-line disease-modifying anti-rheumatic drugs and cardiovascular disease outcomes in patients with rheumatoid arthritis.

  • Authors : Rivera AS; Institute for Public Health and Management, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, United States of America.

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/complications ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use

  • Source: PloS one [PLoS One] 2024 Jun 14; Vol. 19 (6), pp. e0305467. Date of Electronic Publication: 2024 Jun 14 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis.

  • Authors : Su QY; Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.; Shanxi Provincial Key Laboratory of Rheumatism Immune Microecology, The Shanxi Medical University, Taiyuan, Shanxi, China.

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy

  • Source: Journal of translational medicine [J Transl Med] 2024 Aug 28; Vol. 22 (1), pp. 795. Date of Electronic Publication: 2024 Aug 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

تفاصيل العنوان

×
Academic Journal

Time to start disease modifying drugs for adults with seropositive rheumatoid arthritis: results of the first year of the national New Zealand Rheumatology Association (NZRA) audit.

  • Authors : Taylor WJ; Consultant Rheumatologist, Wellington Regional Rheumatology Unit, Capital Coast and Hutt Valley District Health Board, Te Whatu Ora - Health New Zealand, Wellington; Gisborne Hospital, Te Whatu Ora Tairāwhiti, Gisborne

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use; Humans

  • Source: The New Zealand medical journal [N Z Med J] 2024 Aug 02; Vol. 137 (1600), pp. 21-30. Date of Electronic Publication: 2024 Aug 02.Publisher: Pasifika Medical Association Group Country of Publication: New Zealand NLM ID: 0401067 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Effects of IL-6, JAK, TNF inhibitors, and CTLA4-Ig on knee symptoms in patients with rheumatoid arthritis.

  • Authors : Murata K; Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo, Kyoto, 606-8507, Japan. .; Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Sakyo, Kyoto, Japan. .

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Interleukin-6*/Interleukin-6*/Interleukin-6*/antagonists & inhibitors ; Interleukin-6*/Interleukin-6*/Interleukin-6*/metabolism

  • Source: Scientific reports [Sci Rep] 2024 Jul 02; Vol. 14 (1), pp. 15226. Date of Electronic Publication: 2024 Jul 02.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
  • 1-10 ل  1,886 نتائج ل ""Arthritis, Rheumatoid""